[go: up one dir, main page]

ATE298746T1 - Verfahren zur herstellung von substituierten benzimidazolverbindungen - Google Patents

Verfahren zur herstellung von substituierten benzimidazolverbindungen

Info

Publication number
ATE298746T1
ATE298746T1 AT01929529T AT01929529T ATE298746T1 AT E298746 T1 ATE298746 T1 AT E298746T1 AT 01929529 T AT01929529 T AT 01929529T AT 01929529 T AT01929529 T AT 01929529T AT E298746 T1 ATE298746 T1 AT E298746T1
Authority
AT
Austria
Prior art keywords
substituted benzimidazole
benzimidazole compounds
producing substituted
compounds
producing
Prior art date
Application number
AT01929529T
Other languages
English (en)
Inventor
Stephen Freeman
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE298746T1 publication Critical patent/ATE298746T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01929529T 2000-04-11 2001-04-10 Verfahren zur herstellung von substituierten benzimidazolverbindungen ATE298746T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0008939.1A GB0008939D0 (en) 2000-04-11 2000-04-11 Process for preparing substituted benzimidazole compounds
PCT/EP2001/004080 WO2001077083A1 (en) 2000-04-11 2001-04-10 Process for preparing substituted benzimidazole compounds

Publications (1)

Publication Number Publication Date
ATE298746T1 true ATE298746T1 (de) 2005-07-15

Family

ID=9889715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01929529T ATE298746T1 (de) 2000-04-11 2001-04-10 Verfahren zur herstellung von substituierten benzimidazolverbindungen

Country Status (9)

Country Link
US (4) US7101994B2 (de)
EP (2) EP1272473B1 (de)
JP (2) JP4841793B2 (de)
AT (1) ATE298746T1 (de)
AU (1) AU2001256272A1 (de)
DE (1) DE60111732T2 (de)
ES (1) ES2243488T3 (de)
GB (1) GB0008939D0 (de)
WO (1) WO2001077083A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034248A1 (en) 1998-12-04 2000-06-15 Neurosearch A/S New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
CN101675927A (zh) * 2002-06-07 2010-03-24 科蒂科股份有限公司 治疗分子及方法-1
ES2432361T3 (es) * 2005-12-02 2013-12-03 Bayer Healthcare, Llc Derivados de pirrolotriazina útiles para el tratamiento de cáncer por inhibición de cinasa Aurora
US7655004B2 (en) 2007-02-15 2010-02-02 Ethicon Endo-Surgery, Inc. Electroporation ablation apparatus, system, and method
US8888792B2 (en) 2008-07-14 2014-11-18 Ethicon Endo-Surgery, Inc. Tissue apposition clip application devices and methods
US8157834B2 (en) 2008-11-25 2012-04-17 Ethicon Endo-Surgery, Inc. Rotational coupling device for surgical instrument with flexible actuators
US20110098704A1 (en) 2009-10-28 2011-04-28 Ethicon Endo-Surgery, Inc. Electrical ablation devices
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
US9233241B2 (en) 2011-02-28 2016-01-12 Ethicon Endo-Surgery, Inc. Electrical ablation devices and methods
US9254169B2 (en) 2011-02-28 2016-02-09 Ethicon Endo-Surgery, Inc. Electrical ablation devices and methods
CN102952104A (zh) * 2011-08-17 2013-03-06 黑龙江省松花江药业有限公司 一种呋喃类化合物
US9427255B2 (en) 2012-05-14 2016-08-30 Ethicon Endo-Surgery, Inc. Apparatus for introducing a steerable camera assembly into a patient
US9545290B2 (en) 2012-07-30 2017-01-17 Ethicon Endo-Surgery, Inc. Needle probe guide
US10314649B2 (en) 2012-08-02 2019-06-11 Ethicon Endo-Surgery, Inc. Flexible expandable electrode and method of intraluminal delivery of pulsed power
US9277957B2 (en) 2012-08-15 2016-03-08 Ethicon Endo-Surgery, Inc. Electrosurgical devices and methods
US10098527B2 (en) 2013-02-27 2018-10-16 Ethidcon Endo-Surgery, Inc. System for performing a minimally invasive surgical procedure
AU2023361470A1 (en) 2022-10-12 2024-09-19 Takeda Pharmaceutical Company Limited Method of preparing maribavir

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839743A1 (de) * 1988-11-25 1990-05-31 Hoechst Ag Verfahren zur herstellung von benzimidazolonen
DE69016430T2 (de) 1989-06-09 1995-06-01 Upjohn Co Heterozyklische amine mit zns-wirksamkeit.
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
GB9413724D0 (en) 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
AP741A (en) 1994-09-09 1999-04-26 The Wellcome Foundation Ltd Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring.
WO1997007125A1 (en) 1995-08-18 1997-02-27 The Regents Of The University Of Michigan 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
GB9600142D0 (en) 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
GB9600143D0 (en) 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
AU1702597A (en) 1996-01-23 1997-08-20 Glaxo Group Limited Modified benzimidazole nucleosides as antiviral agents
CA2280761A1 (en) 1997-02-13 1998-08-20 Stanley Dawes Chamberlain Benzimidazole derivatives
NZ501415A (en) 1997-06-10 2001-10-26 Glaxo Group Ltd Benzimidazole derivatives (optionally with saccharide substituents) useful for the treatment or prophylaxis of viral infections (particularly herpes, cytomegalovirus and Hepatitis B) or for the treatment or prophylaxis of restenosis
PL338454A1 (en) 1997-07-30 2000-11-06 Univ Michigan Lixofuranosilbenzimidazoles as antiviral agents
GB9807355D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807354D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9815696D0 (en) 1998-07-20 1998-09-16 Pfizer Ltd Heterocyclics

Also Published As

Publication number Publication date
US20090187015A1 (en) 2009-07-23
US20050261211A1 (en) 2005-11-24
US7514568B2 (en) 2009-04-07
JP2011173906A (ja) 2011-09-08
US7858773B2 (en) 2010-12-28
DE60111732T2 (de) 2006-05-04
AU2001256272A1 (en) 2001-10-23
ES2243488T3 (es) 2005-12-01
EP1272473B1 (de) 2005-06-29
JP2003530385A (ja) 2003-10-14
US7101994B2 (en) 2006-09-05
US20030191127A1 (en) 2003-10-09
JP5192061B2 (ja) 2013-05-08
GB0008939D0 (en) 2000-05-31
US7375235B2 (en) 2008-05-20
DE60111732D1 (de) 2005-08-04
JP4841793B2 (ja) 2011-12-21
WO2001077083A1 (en) 2001-10-18
US20080188668A1 (en) 2008-08-07
EP1584620A1 (de) 2005-10-12
EP1272473A1 (de) 2003-01-08

Similar Documents

Publication Publication Date Title
DE60111732D1 (de) Verfahren zur herstellung von substituierten benzimidazolverbindungen
DE502004009142D1 (de) Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen
ATE414077T1 (de) Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten
DE60105732D1 (de) Verfahren zur Herstellung von 3-l-Menthoxypropan-1,2-diol
DE60234952D1 (de) VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL
DE60206996D1 (de) Verfahren zur Herstellung von 3-l-Menthoxypropan-1,2-diol
ATE286011T1 (de) Verfahren zur herstellung von 1-octen
DE60202755D1 (de) Verfahren zur herstellung von imidazolverbindungen
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
ATE358172T1 (de) Verfahren zur herstellung von olefinen.
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE60216931D1 (de) Verfahren zur herstellung von bisphenol-a
DE602004004677D1 (de) Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine
ATE332905T1 (de) Verfahren zur herstellung von acylphosphinoxiden
ATE252589T1 (de) Aluminosiloxanverbindungen und verfahren zu ihrer herstellung
DE60222806D1 (de) Verfahren zur herstellung von (1,4,5)-oxadiazepinderivaten
DE602004030571D1 (de) Verfahren zur herstellung optisch aktiven 1-alkyl-substituierter 2,2,2-trifluorethylamins
DE602004023534D1 (de) Verfahren zur herstellung von optisch aktivem 2-alkylcystein, derivate davon und herstellungsverfahren
DE60230097D1 (de) Verfahren zur herstellung von 1,5-diaminonaphthalinen
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
ATE396166T1 (de) Verfahren zur herstellung von 2,3-cis- substituierten 2-arylpropenalen
ATE425143T1 (de) Verfahren zur herstellung von indolen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties